Thomas Woiwode has an estimated net worth of $1.07 Million. This is based on reported shares across multiple companies, which include Gritstone Oncology, Inc., CRISPR Therapeutics AG, Adverum Biotechnologies, Inc., Aligos Therapeutics, Inc., Millendo Therapeutics, Inc., Passage BIO, Inc., and Audentes Therapeutics, Inc..

2021 was Thomas Woiwode's most active year for acquiring shares with 8 total transactions. Thomas Woiwode's most active month to acquire stocks was the month of May. 2017 was Thomas Woiwode's most active year for disposing of shares, totalling 3 transactions. Thomas Woiwode's most active month to dispose stocks was the month of October. 2019 saw Thomas Woiwode paying a total of $0.00 for 53,570 shares, this is the most they've acquired in one year. In 2018 Thomas Woiwode cashed out on 1,653 shares for a total of $85,046.85, their largest year based on trade value.